| Literature DB >> 32184961 |
Ana Isabel de Lucas1, Juan Antonio Vega1, Encarnación Matesanz1, María Lourdes Linares1, Aránzazu García Molina1, Gary Tresadern2, Hilde Lavreysen3, Andrés A Trabanco1, José María Cid1.
Abstract
Starting from two weak mGlu2 receptor positive allosteric modulator (PAM) HTS hits (4 and 5), a molecular hybridization strategy resulted in the identification of a novel spiro-oxindole piperidine series with improved activity and metabolic stability. Scaffold hopping around the spiro-oxindole core identified the 3-(azetidin-3-yl)-1H-benzimidazol-2-one as bioisoster. Medicinal chemistry optimization of these two novel chemotypes resulted in the identification of potent, selective, orally bioavailable, and brain penetrant mGluR2 PAMs.Entities:
Year: 2019 PMID: 32184961 PMCID: PMC7073870 DOI: 10.1021/acsmedchemlett.9b00350
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345